Статья журнала

Голенков А.В., Щербаков А.А.

Удовлетворенность антиретровирусной терапией и проявления стигмы у ВИЧ-инфицированных

Ключевые слова: приверженность, антиретровирусная терапия, стигма, ВИЧ-инфицированные (ВИЧ+)

Опрос 115 ВИЧ+ (61 мужчина и 54 женщины; от 25 до 59 лет; средний – 35,4±7,5 года) показал, что 79,6% были удовлетворены проводимой антиретровирусной терапией. Более высокие показатели имели мужчины, работающие, отрицающие общественные стереотипы, характерные для ВИЧ+, не имеющие депрессивных, тревожных и стрессовых расстройств. Различные проявления стигматизации и самостигматизации у ВИЧ+ существенно отражались на приверженности больных к терапии.

Golenkov A., Shcherbakov A.

Satisfaction with antiretroviral therapy and manifestations of hiv-related stigma in HIV+ individuals

Keywords: adherence, antiretroviral therapy, stigma, HIV+

The survey of 115 HIV+ individuals (61 men and 54 women from 25 to 59 years old with the average age of 35,4±7,5 years old) showed that 79.6% of them were satisfied with antiretroviral therapy they were undergoing. Adherence was significantly greater among working men, who deny public stereotypes characteristic for HIV+ individuals and do not show any sign of depression, anxiety or stress disorders. Various manifestations of stigmatization and self-stigmatization in HIV+ patients were significantly reflected in their adherence to therapy.

Литература

  1. Голенков А.В. Скрининг злоупотребляющих алкоголем среди ВИЧ-положительных и его значение для лечебно-профилактической работы // Российский медицинский журнал. 2012. № 4. С. 23–25.
  2. Голенков А.В., Гордеева М.С.., Щербаков А.А. Самостигматизация ВИЧ-инфицированных // 20 лет борьбы с ВИЧ/СПИДОМ в России и Чувашии: материалы науч.-практ. конф. Чебоксары, 2009. С. 63–64.
  3. Голенков А.В., Щербаков А.А. Сферы дискриминации ВИЧ-инфицированных (по данным опроса медицинских работников) // Вестник Чувашского университета. 2011. № 3. С. 327–334.
  4. Иванова Е.С. Стресс-ФИЭ: Методика измерения основных видов стресса // Психологическая диагностика. 2008. № 5. С. 82–101.
  5. Табаков В.А., Голенков А.В. Оценка базового уровня знаний медицинских работников о риске заражения ВИЧ-инфекцией при осуществлении профессиональной деятельности. Результаты опроса медицинских работников Чувашской Республики // Заместитель главного врача. 2012. № 5. С. 90–99.
  6. Табаков В.А., Никитин В.В., Голенков А.В. Эпидемиологические и прогностические аспекты заболеваемости наркоманией и ВИЧ-инфекцией на региональном уровне // Наркология. 2007. № 8. С. 28–33.
  7. Al-Dakkak I., Patel S., McCann E. et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis. AIDS Care, 2013, vol. 25, no. 4, pp. 400–414.
  8. Amirkhanian Y.A., Kelly J.A., Kuznetsova A.V. et al. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress. AIDS Behav., 2011, vol. 15, no. 4, pp. 767–777. doi: 10.1007/s10461-010-9793-x.
  9. Baltazary G., Akarro R.R., Mussa A.S. Some factors associated with non-adherence to antiretroviral therapy (ART) in people living with HIV/AIDS (PLHA) in Tanzania: a case study of Dares Salaam region. East Afr. J. Public Health, 2011, vol. 8, no. 4, pp. 237–246.
  10. Cerdá V., Gómez C., González M. et al. Psychometric characteristics of the antiretroviral treatment satisfaction scale (ESTAR): ARPAS study (I). Farm Hosp., 2007, vol. 31, no. 6, pp. 331–339.
  11. Katz I.T., Ryu A.E., Onuegbu A.G. et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J. Int. AIDS Soc., 2013, vol. 16, no. 3, suppl. 2, p. 18640. doi: 10.7448/IAS.16.3.18640.
  12. Lowther K., Selman L., Harding R., Higginson I. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): A systematic review. J. Nurs. Stud., 2014, vol. 51, no. 8, pp. 1171–1189.
  13. Mhaskar R., Alandikar V., Emmanuel P. et al. Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. J. Community Med., 2013, vol. 38, no. 2, pp. 74–82.
  14. Muya A.N., Geldsetzer P., Hertzmark E. et al. Predictors of Nonadherence to Antiretroviral Therapy among HIV-Infected Adults in Dar Es Salaam, Tanzania. Int. Assoc. Provid. AIDS Care, 2014, Jun 25, pii: 2325957414539193.
  15. Nischal K.C., Khopkar U., Saple D.G. Improving adherence to antiretroviral therapy. J. Dermatol. Venereol Leprol., 2005, vol. 71, no. 5, pp. 16–20.
  16. Ortego C., Huedo-Medina T.B., Santos P. et al. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis. AIDS Care, 2012, vol. 24, no. 12, pp. 1519–1534.
  17. Ortego C., Huedo-Medina T.B., Vejo J., Llorca F.J. Adherence to highly active antiretroviral therapy in Spain. A meta-analysis. Sanit., 2011, vol. 25, no. 4, pp. 282–289.
  18. Sin N.L., DiMatteo M.R. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Behav. Med., 2014, vol. 47, no. 3, pp. 259–269.
  19. Shaboltas A.V., Skochilov R.V., Brown L.B. et al. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia. Reduct. J., 2013, vol. 10, no. 1:15. doi: 10.1186/1477-7517-10-15.
  20. Uys L.R., Holzemer W.L., Chirwa M.L. et a The development and validation of the HIV/AIDS Stigma Instrument – Nurse (HASI-N). AIDS Care, 2009, vol. 21, no. 2, pp. 150–159.

References

  1. Golenkov A.V. Skrining zloupotreblyayushchikh alkogolem sredi VICh-polozhitel’nykh i ego znachenie dlya lechebno-profilakticheskoi raboty [The screening of HIV-positive patients suffering from alcohol abuse and its significance for treatment and prevention]. Rossiiskii meditsinskii zhurnal [Russian medical journal], 2012, no. 4, pp. 23–25.
  2. Golenkov A.V., Gordeeva M.S., Shcherbakov A.A. Samostigmatizatsiya VICh-infitsirovannykh [Self-stigmatization of HIV-infected patients]. 20 let bor’by s VICh/SPIDOM v Rossii i Chuvashii: materialy nauch.-prakt. konf. [Proc. of conf. «20 years of fight against HIV/AIDS in Russia and Chuvashia»]. Cheboksary, 2009, pp. 63–64.
  3. Golenkov A.V., Shcherbakov A.A. Sfery diskriminatsii VICh-infitsirovannykh (po dannym oprosa meditsinskikh rabotnikov) [Spheres of HIV-infected patients discrimination (based on results of medical workers survey)]. Vestnik Chuvashskogo universiteta, 2011, no. 3, pp. 327–334.
  4. Ivanova E.S. Stress-FIE: Metodika izmereniya osnovnykh vidov stressa [Stress-FIE: Techniques for measuring the main types of stress]. Psikhologicheskaya diagnostika [Psychological diagnostics], 2008, no. 5, pp. 82–101.
  5. Tabakov V.A., Golenkov A.V. Otsenka bazovogo urovnya znanii meditsinskikh rabotnikov o riske zarazheniya VICh-infektsiei pri osushchestvlenii professional’noi deyatel’nosti. Rezul’taty oprosa meditsinskikh rabotnikov Chuvashskoi Respubliki [Assessment of a basic level of knowledge of health workers of risk of infection with HIV infection at implementation of professional activity. Results of poll of health workers of the Chuvash Republic]. Zamestitel’ glavnogo vracha [Deputy of chief physician], 2012, no. 5, pp. 90–99.
  6. Tabakov V.A., Nikitin V.V., Golenkov A.V. Epidemiologicheskie i prognosticheskie aspekty zabolevaemosti narkomaniei i VICh-infektsiei na regional’nom urovne [Epidemiological and predictive aspects of incidence of drug addiction and HIV infection at the regional level]. Narkologiya [Narcology], 2007, no. 8, pp. 28–33.
  7. Al-Dakkak I., Patel S., McCann E. et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis. AIDS Care, 2013, vol. 25, no. 4, pp. 400–414.
  8. Amirkhanian Y.A., Kelly J.A., Kuznetsova A.V. et al. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress. AIDS Behav., 2011, vol. 15, no. 4, pp. 767–777. doi: 10.1007/s10461-010-9793-x.
  9. Baltazary G., Akarro R.R., Mussa A.S. Some factors associated with non-adherence to antiretroviral therapy (ART) in people living with HIV/AIDS (PLHA) in Tanzania: a case study of Dares Salaam region. East Afr. J. Public Health, 2011, vol. 8, no. 4, pp. 237–246.
  10. Cerdá V., Gómez C., González M. et al. Psychometric characteristics of the antiretroviral treatment satisfaction scale (ESTAR): ARPAS study (I). Farm Hosp., 2007, vol. 31, no. 6, pp. 331–339.
  11. Katz I.T., Ryu A.E., Onuegbu A.G. et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J. Int. AIDS Soc., 2013, vol. 16, no. 3, suppl. 2, p. 18640. doi: 10.7448/IAS.16.3.18640.
  12. Lowther K., Selman L., Harding R., Higginson I. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): A systematic review. J. Nurs. Stud., 2014, vol. 51, no. 8, pp. 1171–1189.
  13. Mhaskar R., Alandikar V., Emmanuel P. et al. Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. J. Community Med., 2013, vol. 38, no. 2, pp. 74–82.
  14. Muya A.N., Geldsetzer P., Hertzmark E. et al. Predictors of Nonadherence to Antiretroviral Therapy among HIV-Infected Adults in Dar Es Salaam, Tanzania. Int. Assoc. Provid. AIDS Care, 2014, Jun 25, pii: 2325957414539193.
  15. Nischal K.C., Khopkar U., Saple D.G. Improving adherence to antiretroviral therapy. J. Dermatol. Venereol Leprol., 2005, vol. 71, no. 5, pp. 16–20.
  16. Ortego C., Huedo-Medina T.B., Santos P. et al. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis. AIDS Care, 2012, vol. 24, no. 12, pp. 1519–1534.
  17. Ortego C., Huedo-Medina T.B., Vejo J., Llorca F.J. Adherence to highly active antiretroviral therapy in Spain. A meta-analysis. Sanit., 2011, vol. 25, no. 4, pp. 282–289.
  18. Sin N.L., DiMatteo M.R. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Behav. Med., 2014, vol. 47, no. 3, pp. 259–269.
  19. Shaboltas A.V., Skochilov R.V., Brown L.B. et al. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia. Reduct. J., 2013, vol. 10, no. 1:15. doi: 10.1186/1477-7517-10-15.
  20. Uys L.R., Holzemer W.L., Chirwa M.L. et al. The development and validation of the HIV/AIDS Stigma Instrument – Nurse (HASI-N). AIDS Care, 2009, vol. 21, no. 2, pp. 150–159.

Сведения об авторах

ГОЛЕНКОВ АНДРЕЙ ВАСИЛЬЕВИЧ
доктор медицинских наук, профессор, заведующий кафедрой психиатрии, медицинской психологии и неврологии, Чувашский государственный университет, Россия, Чебоксары (golenkovav@inbox.ru).
GOLENKOV ANDREI
M.D., Professor, Head of Psychiatry, Medical Psychology and Neurology Department, Chuvash State University, Cheboksary, Russia.
ЩЕРБАКОВ АЛЕКСЕЙ АЛЕКСЕЕВИЧ
главный врач, Республиканский центр по профилактике и борьбе со СПИДом и инфекционными заболеваниями; главный внештатный эпидемиолог, Министерство здравоохранения и социального развития Чувашской Республики, Россия, Чебоксары (ipspid@medinform.su).
SHCHERBAKOV ALEXEY
Head Doctor, Republican Center of AIDS and Infectious Diseases Prevention and Control; Сhief Non-staff Epidemiologist, Ministry of Health Care and Social Development of the Chuvash Republic, Cheboksary, Russia.

Ссылка на статью

Голенков А.В., Щербаков А.А. Удовлетворенность антиретровирусной терапией и проявления стигмы у ВИЧ-инфицированных [Электронный ресурс] // Acta medica Eurasica. – 2015. – №2. – С. . – URL: http://acta-medica-eurasica.ru/single/2015/2/4/.